Pesek, Robert D. http://orcid.org/0000-0002-3136-0039
,
Reed, Craig C.
Collins, Margaret H.
Muir, Amanda B.
Fulkerson, Patricia C.
Menard-Katcher, Calies
Falk, Gary W.
Kuhl, Jonathan
Magier, Adam Z.
Ahmed, Faria N.
Demarshall, Maureen
Gupta, Ankur
Gross, Jonathan
Ashorobi, Tokunbo
Carpenter, Christina L.
Krischer, Jeffrey P.
Gonsalves, Nirmala
Hirano, Ikuo
Spergel, Jonathan M.
Gupta, Sandeep K.
Furuta, Glenn T.
Rothenberg, Marc E.
Dellon, Evan S.
Funding for this research was provided by:
National Institutes of Health (U54 AI117804, T32 DK007634)
Article History
Received: 7 August 2019
Accepted: 13 November 2019
First Online: 26 November 2019
Compliance with Ethical Standards
:
: As a corresponding author, I declare the disclosures and potential conflicts of interest listed below on behalf of all authors. This has been verified to be accurate and up to date at the time of submission of the manuscript. In addition to the disclosures below, this study was funded in part through a research training grant as a part of the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) (U54 AI117804). CEGIR is part of the Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), NCATS, and is funded through collaboration between NIAID, NIDDK, and NCATS. CEGIR is also supported by patient advocacy groups including APFED CURED and EFC. This project also received support from NIH T32 DK007634 (CCR).